Worthington Mark
Insider CIK 1861464 · ATHA General Counsel and CCO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LONA LeonaBio, Inc. | A Award deriv | 2026-04-09 | 2026-04-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| LONA LeonaBio, Inc. | S Sale | 2026-03-04 | 2026-03-05 | 1,328 | $5.37 | $7.1K | 18,376 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise deriv | 2026-03-03 | 2026-03-05 | 5,726 | — | $0 | 0 | SEC↗ |
| LONA LeonaBio, Inc. | M Exercise | 2026-03-03 | 2026-03-05 | 5,726 | — | $0 | 19,704 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2026-01-02 | 2026-01-05 | 876 | $6.88 | $6.0K | 13,978 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-05 | 3,667 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2025-12-31 | 2026-01-05 | 3,667 | — | $0 | 14,854 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-12-24 | 2025-12-29 | 34,358 | — | $0 | 34,358 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2025-07-01 | 2025-07-02 | 8,526 | $0.29 | $2.5K | 111,875 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2025-06-30 | 2025-07-02 | 36,666 | — | $0 | 36,667 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2025-06-30 | 2025-07-02 | 36,666 | — | $0 | 120,401 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 85,895 | — | $0 | 85,895 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2025-03-03 | 2025-03-04 | 57,263 | — | $0 | 57,263 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 8,510 | $0.56 | $4.8K | 83,735 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 36,667 | — | $0 | 73,333 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 36,667 | — | $0 | 92,245 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-11-18 | 2025-01-03 | 3,651 | $0.55 | $2.0K | 55,578 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2024-09-05 | 2024-09-05 | 2,525 | $0.57 | $1.4K | 51,927 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-09-03 | 2024-09-05 | 10,000 | — | $0 | 54,452 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-05-20 | 2024-09-05 | 10,000 | $1.34 | $13.4K | 44,452 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 220,000 | — | $0 | 220,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2024-01-05 | 2024-01-08 | 2,412 | $2.91 | $7.0K | 34,452 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2024-01-05 | 2024-02-16 | 2,412 | $2.91 | $7.0K | 34,452 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-01-04 | 2024-01-08 | 10,000 | — | $0 | 36,864 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2024-01-04 | 2024-02-16 | 10,000 | — | $0 | 36,864 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2023-05-18 | 2024-01-08 | 7,767 | $2.41 | $18.7K | 26,864 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2023-05-18 | 2024-02-16 | 7,767 | $2.41 | $18.7K | 26,864 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2023-01-19 | 2023-01-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2022-06-23 | 2022-06-24 | 2,614 | $2.69 | $7.0K | 19,097 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-06-22 | 2022-06-24 | 10,000 | — | $0 | 21,711 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-05-18 | 2022-06-24 | 3,396 | $7.06 | $24.0K | 11,711 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2022-01-18 | 2022-01-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2021-11-03 | 2021-11-05 | 150,000 | — | $0 | 150,000 | SEC↗ |